Amgen (AMGN) Tops Q1 EPS by 41c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. SPY
3. PTC
4. PCVX
5. META
6. MSFT
7. AMD
8. GMAB
9. USO
10. AMZN

Go back to Amgen (AMGN) Tops Q1 EPS by 41c

Amgen Reports First Quarter 2020 Financial Results

April 30, 2020 4:01 PM EDT

THOUSAND OAKS, Calif., April 30, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the first quarter of 2020 and discussed the company's response to the COVID-19 pandemic.

First Quarter Performance

Key results include:

Total revenues increased 11% to $6.2 billion in comparison to the first quarter of 2019, driven by higher unit demand, offset partially by lower net selling prices. Product sales increased 12% globally, driven by volume growth across a number of our newer products, including Otezla® (apremilast), Repatha® (evolocumab), MVASI® (bevacizumab-awwb), KANJINTI® (trastuzumab-anns)... More